Rafferty Asset Management
INBX

Rafferty Asset Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Rafferty Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-201,948
Closed -$7.06M – 1213
2024
Q1 		$7.06M Buy
201,948
+98,702
+96% +$3.6M 0.03% 377
2023
Q4 		$3.92M Sell
103,246
-12,582
-11% -$270K 0.02% 498
2023
Q3 		$2.13M Sell
115,828
-16,456
-12% -$344K 0.01% 597
2023
Q2 		$3.43M Sell
132,284
-22,739
-15% -$531K 0.02% 499
2023
Q1 		$2.93M Sell
155,023
-41,769
-21% -$971K 0.02% 517
2022
Q4 		$4.85M Buy
196,792
+63,793
+48% +$1.88M 0.04% 381
2022
Q3 		$2.39M Buy
+132,999
New +$2.4M 0.03% 468
2022
Q2 		– Sell
-95,034
Closed -$2.12M – 1272
2022
Q1 		$2.12M Buy
95,034
+56,121
+144% +$1.43M 0.01% 587
2021
Q4 		$1.7M Buy
+38,913
New +$1.56M 0.01% 716

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Rafferty Asset Management's INBX Position: Q2 2024 in Review

Rafferty Asset Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 201,948 shares — an estimated $7.06M sold.

Rafferty Asset Management first reported a position in INBX in Q4 2021 and held it in 9 quarters. The position peaked at $7.06M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Rafferty Asset Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 201,948 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $7.06M.
  • Rafferty Asset Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Rafferty Asset Management's Inhibrx, Inc. Common Stock position peaked at $7.06M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.